
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $555M | $663.2M | $704.3M | $663.6M | $696.2M | |
Revenue Growth (YoY) | -1.38% | 19.5% | 6.2% | -5.77% | 4.91% | |
Cost of Revenues | $204M | $249.7M | $273.1M | $240.5M | $253.5M | |
Gross Profit | $351M | $413.4M | $431.1M | $423.2M | $442.7M | |
Gross Profit Margin | 63.25% | 62.35% | 61.22% | 63.77% | 63.58% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $72.4M | $76.4M | $83.3M | $76M | $76.4M | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $278.4M | $303M | $307M | $301.2M | $320.8M | |
Operating Income | $72.6M | $110.5M | $124.1M | $122M | $121.8M | |
Net Interest Expenses | $8.4M | $8M | $7.4M | $13.5M | $15.3M | |
EBT. Incl. Unusual Items | $52.7M | $101.3M | $116.2M | $106.2M | $100.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.4M | $24.7M | $27.8M | $25.3M | $23.2M | |
Net Income to Company | $52.7M | $101.3M | $116.2M | $106.2M | $100.1M | |
Minority Interest in Earnings | $6.1M | $3.7M | $4.3M | $1.3M | -$556.8K | |
Net Income to Common Excl Extra Items | $46.3M | $80.3M | $92.7M | $82.2M | $76.4M | |
Basic EPS (Cont. Ops) | $0.93 | $1.61 | $1.86 | $1.65 | $1.53 | |
Diluted EPS (Cont. Ops) | $0.93 | $1.61 | $1.85 | $1.65 | $1.53 | |
Weighted Average Basic Share | $49.8M | $49.8M | $49.9M | $49.9M | $49.9M | |
Weighted Average Diluted Share | $49.9M | $49.9M | $50M | $50M | $49.9M | |
EBITDA | $108.7M | $157.2M | $172M | $168.7M | $170.1M | |
EBIT | $61M | $108.5M | $125.3M | $122.4M | $118M | |
Revenue (Reported) | $555M | $663.2M | $704.3M | $663.6M | $696.2M | |
Operating Income (Reported) | $72.6M | $110.5M | $124.1M | $122M | $121.8M | |
Operating Income (Adjusted) | $61M | $108.5M | $125.3M | $122.4M | $118M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Revenue | $180.1M | $184.5M | $182.9M | $180.6M | $198.2M | |
Revenue Growth (YoY) | 33.14% | 2.44% | -0.84% | -1.28% | 9.72% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $142.7M | $149.2M | $143.9M | $145.9M | $161.5M | |
Operating Income | $37.4M | $35.3M | $39M | $34.7M | $36.6M | |
Net Interest Expenses | $2.1M | $1.8M | $3.7M | $4.8M | $5M | |
EBT. Incl. Unusual Items | $35.3M | $34.1M | $35.3M | $29.8M | $31.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $8M | $8.3M | $8.5M | $7.1M | $7.3M | |
Net Income to Company | $35.7M | $32.2M | $34.1M | $29.3M | $33.7M | |
Minority Interest in Earnings | $476.8K | $846.3K | -$466K | -$92.7K | $387.6K | |
Net Income to Common Excl Extra Items | $27.8M | $26.7M | $26.4M | $22.6M | $24.7M | |
Basic EPS (Cont. Ops) | $0.56 | $0.54 | $0.53 | $0.45 | $0.50 | |
Diluted EPS (Cont. Ops) | $0.56 | $0.53 | $0.53 | $0.45 | $0.50 | |
Weighted Average Basic Share | $49.8M | $49.8M | $49.8M | $49.8M | $49.8M | |
Weighted Average Diluted Share | $49.9M | $50M | $49.8M | $49.8M | $49.8M | |
EBITDA | $49.2M | $47.5M | $50M | $47.3M | $50.6M | |
EBIT | $37.1M | $35.8M | $39M | $34.7M | $36.6M | |
Revenue (Reported) | $180.1M | $184.5M | $182.9M | $180.6M | $198.2M | |
Operating Income (Reported) | $37.4M | $35.3M | $39M | $34.7M | $36.6M | |
Operating Income (Adjusted) | $37.1M | $35.8M | $39M | $34.7M | $36.6M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Revenue | $620.9M | $683.9M | $701.2M | $679.3M | $721M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $314.6M | $319.5M | $317.1M | $563.5M | $595.9M | |
Operating Income | $93.7M | $118.6M | $126.6M | $115.9M | $125.1M | |
Net Interest Expenses | $8.6M | $6.9M | $10.8M | $17.7M | $15.5M | |
EBT. Incl. Unusual Items | $83.6M | $110.9M | $115.2M | $97.3M | $106.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $17.6M | $27.6M | $27.4M | $22.9M | $24.4M | |
Net Income to Company | $84.6M | $108.4M | $115.4M | $97.7M | $108.6M | |
Minority Interest in Earnings | $4.5M | $3.5M | $3M | $723.7K | $571.2K | |
Net Income to Common Excl Extra Items | $70.5M | $86.8M | $90.8M | $75.1M | $82.3M | |
Basic EPS (Cont. Ops) | $1.42 | $1.74 | $1.82 | $1.51 | $1.65 | |
Diluted EPS (Cont. Ops) | $1.41 | $1.74 | $1.82 | $1.51 | $1.65 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $141M | $165.7M | $172.4M | $164M | $175.9M | |
EBIT | $91.4M | $117.6M | $127.6M | $114.6M | $122.3M | |
Revenue (Reported) | $620.9M | $683.9M | $701.2M | $679.3M | $721M | |
Operating Income (Reported) | $93.7M | $118.6M | $126.6M | $115.9M | $125.1M | |
Operating Income (Adjusted) | $91.4M | $117.6M | $127.6M | $114.6M | $122.3M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Revenue | $346.2M | $366.4M | $363.4M | $367.9M | $381.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $285.9M | $298.3M | $293.1M | $304M | $312M | |
Operating Income | $60.2M | $68.1M | $70.3M | $63.9M | $69.7M | |
Net Interest Expenses | $4.5M | $3.4M | $6.8M | $9M | $7.2M | |
EBT. Incl. Unusual Items | $55.9M | $65.3M | $63.8M | $54.6M | $60.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $13M | $15.9M | $15.4M | $12.9M | $14M | |
Net Income to Company | $56.3M | $63.4M | $62.5M | $54M | $62.5M | |
Minority Interest in Earnings | $2M | $1.7M | $509.4K | -$92.7K | $1M | |
Net Income to Common Excl Extra Items | $44.9M | $51.1M | $48.9M | $41.6M | $47.3M | |
Basic EPS (Cont. Ops) | $0.90 | $1.03 | $0.98 | $0.84 | $0.95 | |
Diluted EPS (Cont. Ops) | $0.90 | $1.02 | $0.98 | $0.83 | $0.95 | |
Weighted Average Basic Share | $99.4M | $99.6M | $99.6M | $99.6M | $99.6M | |
Weighted Average Diluted Share | $99.7M | $99.9M | $99.8M | $99.7M | $99.6M | |
EBITDA | $84.2M | $92.5M | $92.6M | $88.4M | $95.6M | |
EBIT | $59.5M | $68.4M | $70.4M | $63.1M | $68.6M | |
Revenue (Reported) | $346.2M | $366.4M | $363.4M | $367.9M | $381.7M | |
Operating Income (Reported) | $60.2M | $68.1M | $70.3M | $63.9M | $69.7M | |
Operating Income (Adjusted) | $59.5M | $68.4M | $70.4M | $63.1M | $68.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $24M | $14.1M | $23.9M | $46.1M | $6.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $89.4M | $87.3M | $100.8M | $86.2M | $94.6M | |
Inventory | $103.9M | $89.8M | $132.5M | $142.3M | $132.1M | |
Prepaid Expenses | $20.4M | $19.6M | $29.3M | $22.3M | $26.5M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $251.3M | $229.3M | $297.9M | $306.5M | $266.5M | |
Property Plant And Equipment | $510M | $514.9M | $481.2M | $510.1M | $488.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4M | $3.6M | $3.5M | $3.6M | $3.4M | |
Other Intangibles | $6.1M | $6.5M | $4.9M | $4.6M | $4.3M | |
Other Long-Term Assets | -- | -- | -- | -- | $46.2M | |
Total Assets | $820.3M | $812.4M | $827.9M | $896.2M | $845.3M | |
Accounts Payable | $42.3M | $49.3M | $50.7M | $55.1M | $48.6M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $117.1K | $113.4K | $612.2K | $884.9K | $793.8K | |
Total Current Liabilities | $181.9M | $145.4M | $204.5M | $177.4M | $164.8M | |
Long-Term Debt | $161.8M | $149.6M | $139.8M | $198.2M | $179.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $377.8M | $324.2M | $374.4M | $415M | $396.4M | |
Common Stock | $11.7M | $11.3M | $10.2M | $9.8M | $8.8M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $429.7M | $478.6M | $448.3M | $477.4M | $444.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $12.9M | $9.5M | $5.2M | $3.8M | $4.3M | |
Total Equity | $442.6M | $488.1M | $453.5M | $481.2M | $448.9M | |
Total Liabilities and Equity | $820.3M | $812.4M | $827.9M | $896.2M | $845.3M | |
Cash and Short Terms | $24M | $14.1M | $23.9M | $46.1M | $6.4M | |
Total Debt | $234.7M | $175M | $211.4M | $222.4M | $204.9M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $28.7M | $9.1M | $33.8M | $27.9M | $9.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $148.7M | $148.5M | $145.8M | $134M | $173M | |
Inventory | $89.8M | $104.6M | $122M | $121.6M | $145.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $267.2M | $262.2M | $301.6M | $283.5M | $327.8M | |
Property Plant And Equipment | $511.3M | $466.8M | $453.9M | $473.5M | $545.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $31.8M | $24M | $20.9M | $35M | $63.2M | |
Total Assets | $825.8M | $776.2M | $807.7M | $823.7M | $988.3M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $107.9M | $115.7M | $141.6M | $124.3M | $131.8M | |
Total Current Liabilities | $167.3M | $143.2M | $192.2M | $167.2M | $200M | |
Long-Term Debt | $157.2M | $194.7M | $188.6M | $179.8M | $175.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $362M | $374.4M | $425.1M | $379.8M | $425.1M | |
Common Stock | $11.7M | $10.1M | $9.3M | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $11.2M | $7.7M | $4.7M | $3.8M | $3.4M | |
Total Equity | $463.8M | $401.8M | $382.6M | $443.9M | $563.3M | |
Total Liabilities and Equity | $825.8M | $776.2M | $807.7M | $823.7M | $988.3M | |
Cash and Short Terms | $28.7M | $9.1M | $33.8M | $27.9M | $9.5M | |
Total Debt | $216.5M | $222.2M | $239.2M | $222.7M | $243.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $52.7M | $101.3M | $116.2M | $106.2M | $100.1M | |
Depreciation & Amoritzation | $47.7M | $48.7M | $46.7M | $46.3M | $52.1M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $94.1M | $166.1M | $76.4M | $147.7M | $99.1M | |
Capital Expenditures | $53.4M | $64.5M | $48.2M | $63M | $66M | |
Cash Acquisitions | -- | -$16.8M | -- | -$16.2M | -$13.9M | |
Cash From Investing | -$51.9M | -$80.3M | -$47.3M | -$78.3M | -$78.1M | |
Dividends Paid (Ex Special Dividend) | -$24.3M | -$28.9M | -$51.9M | -$30.6M | -$34.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $87M | $78.7M | $53.3M | |
Long-Term Debt Repaid | -$180.8M | -$94.5M | -$53.2M | -$79.6M | -$67.2M | |
Repurchase of Common Stock | -$6.6M | -$13.7M | -$7.1M | -$8.7M | -$9.1M | |
Other Financing Activities | $167.5M | $33.1M | -$103.9K | -$3.6M | -$10.1M | |
Cash From Financing | -$40.5M | -$97.1M | -$21M | -$39.2M | -$63M | |
Beginning Cash (CF) | $8.6M | $11.1M | $519.7K | $10.5M | $39.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.7M | -$11.4M | $8.1M | $30.1M | -$42M | |
Ending Cash (CF) | $10.2M | $580.2K | $11.5M | $40.5M | -$278.4K | |
Levered Free Cash Flow | $40.7M | $101.5M | $28.2M | $84.7M | $33.1M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $35.7M | $32.2M | $34.1M | $29.3M | $33.7M | |
Depreciation & Amoritzation | $12.4M | $11M | $10.5M | $12.3M | $14.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $55.1M | $19.7M | $37.8M | $51M | $38.2M | |
Capital Expenditures | $15.1M | $8M | $12.3M | $15.7M | $18.8M | |
Cash Acquisitions | -- | -- | -$11.6M | -- | -$5.3M | |
Cash From Investing | -$15.2M | -$7.6M | -$23.6M | -$15.3M | -$23.6M | |
Dividends Paid (Ex Special Dividend) | -$29.7M | -$52.8M | -$30.2M | -$34.7M | -$41.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | $936.3K | -- | -- | -- | -- | |
Repurchase of Common Stock | -$3.9M | -$2M | -$567.5K | -$2.5M | -$261.2K | |
Other Financing Activities | -$4.6M | $37M | $32.1M | $13.8M | $17.9M | |
Cash From Financing | -$35.2M | -$17.2M | $1.5M | -$22.1M | -$23.1M | |
Beginning Cash (CF) | $11.7M | -$1.8M | $10.2M | $7.7M | $5.9M | |
Foreign Exchange Rate Adjustment | $474.6K | $2.9M | $383.4K | -$694.1K | $56.4K | |
Additions / Reductions | $4.7M | -$5.1M | $15.8M | $13.6M | -$8.5M | |
Ending Cash (CF) | $17M | -$4M | $25.9M | $19.6M | -$2.6M | |
Levered Free Cash Flow | $40M | $11.8M | $25.5M | $35.3M | $19.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $84.6M | $108.4M | $115.4M | $97.7M | $108.6M | |
Depreciation & Amoritzation | $50.4M | $47.1M | $45.1M | $49.6M | $54.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $145.6M | $94.6M | $113.4M | $132.7M | $115.3M | |
Capital Expenditures | $58.4M | $56.1M | $53.2M | $66.9M | $71.1M | |
Cash Acquisitions | -- | -$16.8M | -$11.6M | -$4.6M | -$19.2M | |
Cash From Investing | -$57.1M | -$71.6M | -$64M | -$70.4M | -$88.3M | |
Dividends Paid (Ex Special Dividend) | -$31.2M | -$52M | -$29.3M | -$35.1M | -$41.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$12.1M | -$5.6M | -$9.2M | -$9.3M | -$5.1M | |
Other Financing Activities | $150.4M | $100.3M | -$21M | -$26.6M | $7.4M | |
Cash From Financing | -$67.4M | -$46.9M | -$20.8M | -$66.8M | -$49.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $21.1M | -$23.8M | $28.6M | -$4.6M | -$22.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $87.2M | $38.5M | $60.2M | $65.8M | $44.2M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $56.3M | $63.4M | $62.5M | $54M | $62.5M | |
Depreciation & Amoritzation | $24.9M | $23.3M | $21.7M | $25M | $27.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $83.1M | $11.6M | $48.6M | $33.6M | $49.8M | |
Capital Expenditures | $26.2M | $17.8M | $22.7M | $26.6M | $31.7M | |
Cash Acquisitions | -- | -- | -$11.6M | -- | -$5.3M | |
Cash From Investing | -$25.9M | -$17.1M | -$33.8M | -$25.9M | -$36.1M | |
Dividends Paid (Ex Special Dividend) | -$29.7M | -$52.8M | -$30.2M | -$34.7M | -$41.1M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$10.5M | -$2.4M | -$4.6M | -$5.2M | -$1.2M | |
Other Financing Activities | -$17.3M | $49.9M | $29.1M | $6.1M | $23.6M | |
Cash From Financing | -$52M | -$1.7M | -$1.5M | -$29.1M | -$15.5M | |
Beginning Cash (CF) | $22.9M | -$1.2M | $21.1M | $48.4M | $5.6M | |
Foreign Exchange Rate Adjustment | $357.6K | $2.6M | $2.2M | $1.3M | -$484.5K | |
Additions / Reductions | $5.2M | -$7.2M | $13.3M | -$21.4M | -$1.8M | |
Ending Cash (CF) | $28.7M | -$5.8M | $36.1M | $27.3M | $3.2M | |
Levered Free Cash Flow | $56.9M | -$6.1M | $25.9M | $7M | $18.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.